The value of transformed lymphocyte count in subclassification of non- Hodgkin's lymphoma by fine-needle aspiration

American Journal of Clinical Pathology

Volumn 108, Issue 2, 1997, Pages 143-151

  Young, Nancy A ^a   Al Saleem, Tahseen I ^a   Al Saleem, Zina ^a   Ehya, Hormoz ^a   Smith, Mitchell R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Classification; Cytology; Diagnosis; Fine needle aspiration; Flow cytometry; Lymphocyte transformation; Lymphoma; Needle biopsy; Pathology

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; CANCER CLASSIFICATION; CANCER GRADING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFORMATION; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PAPANICOLAOU TEST; PRIORITY JOURNAL;

EID: 0030852744     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.2.143     Document Type: Article

References (24)

1. Carter T, Feldman P, Innes D, Frierson H, Frigy A. The role of FNA cytology in the diagnosis of lymphoma. Acta Cytol. 1988;32:848-853.
2. Pitts W, Weiss L. Fine needle aspiration biopsy of lymph nodes. In: Rosen PP, Fechner RE, eds. Pathol Annu. 1988;23:329-360.
3. Hajdu SI, Melamed M. Limitations of aspiration cytology in the diagnosis of primary neoplasm. Acta Cytol. 1984;28:337-345.
4. Chernoff WG, Lampe HB, Cramer H, Banerjee D. The potential clinical impact of the fine needle aspiration/flow cytometric diagnosis of malignant lymphoma. J Otolaryngol. 1992;21:1-15.
5. Gupta AK, Nayar M, Chandra M. Reliability and limitations of fine needle aspiration cytology of lymphadenopathies: an analysis of 1,261 cases. Acta Cytol. 1991;35:777-783.
6. Pontifex AH, Klimo P. Application of aspiration biopsy cytology to lymphomas. Cancer. 1984;53:553-556
7. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
8. Rappaport H. Tumors of the hematopoietic system. In: Atlas of Tumor Pathology, Section III, Fascicle 8. Washington, DC: Armed Forces Institute of Pathology; 1966:97-161.
9. Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer. 1974;34:1488-1503.
10. Lennert K, Mohri N. Histopathology and diagnosis of non-Hodgkin's lymphomas. In: Lennert K, Stein H, Mohri N, Kaiscerling E, Muller-Hermelink HK, eds. Malignant Lymphomas Other Than Hodgkin's Disease. Berlin, Germany: Springer-Verlag; 1978:111-169.
11. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute-sponsored study of classification of non-Hodgkin's lymphoma: summary and description of a working formulation for clinical usage. Cancer. 1982;49:2112-2135.
12. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol. 1983;1:187-192.
13. Kardos T, Maygarden S, Blumberg A, Wakely P, Frable W. FNA biopsy in the management of children and young adults with peripheral lymphadenopathy. Cancer. 1989;63:703-707.
14. Pontiflex AH, Klimo P. Application of aspiration biopsy cytology to lymphomas. Cancer. 1984;53:553-556.
15. Russel J, Orell S, Skinner J, Seshadri R. Fine needle aspiration cytology in the management of lymphoma. Aust N Z J Med. 1983;13:365-368.
16. Cartagena N Jr, Katz RL, Girsch-Ginsberg C, Childs CC, Ordonez NG, Cabanillas F. Accuracy of diagnosis of malignant lymphoma by combining fine-needle aspiration cytomorphology with immunocytochemistry and in selected cases, Southern blotting of aspirated cells: a tissue-controlled study of 86 patients. Diagn Cytopathol. 1992;8:456-464.
17. Tani E, Christenson B, Powit A, Skoog L. Immunocytochemical analysis and cytomorphologic diagnosis on FNA of lymphoproliferative disease. Acta Cytol. 1988;32:200-215.
18. Joensuu H, Pekka Y, Eerola E. Diagnostic value of DNA flow cytometry combined with FNA biopsy in lymphomas. J Pathol. 1988;154:237-245.
19. Lubinski J, Chosia M, Huebner K. Molecular genetic analysis in the diagnosis of lymphoma in fine needle aspiration biopsies, part 2: lymphomas vs non-lymphoid malignant tumors. Anal Quant Cytol Histol. 1988;10:399-430.
20. Katz RL, Hirsch-Ginsberg C, Childs C, et al. The role of gene rearrangements for antigen receptors in the diagnosis of lymphoma obtained by fine-needle aspiration: a study of 63 cases with concomitant immunophenotyping. Am J Clin Pathol. 1991;96:479-490.
21. Al-Saleem T, Schilder RJ, Millenson M, Smith MR. Reclassification of lymphoid neoplasms into newly recognized entities by flow cytometric immunophenotyping. Blood. 1995;86:533a. Abstract.
22. Mann RB, Jaffe ES, Berard CW: Malignant lymphomas: a conceptual understanding of morphologic diversity. Am J Pathol. 1979;94:105-192.
23. Jaffe ES, Raffeld M, Medeiros J. Histopathologic subtypes of indolent lymphomas: caricatures of the mature B-cell system. Semin Oncol. 1993;20:3-30.
24. Metter GE, Nathwani BN, Burke JS, et al. Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists: a collaborative study between the repository center and pathology panel for lymphoma clinical studies. J Clin Oncol. 1985;3:25-38.